Lessons from an Educational Invasive Fungal Disease Conference on Hospital Antifungal Stewardship Practices across the UK and Ireland
Abstract
:1. Introduction
2. AFS in the UK and Ireland
3. AFS Implementation
3.1. Surveillance
3.2. Diagnostics
3.3. Screening
3.4. Treatment Strategies
4. AFS and Practice Guidance
5. Discussion
6. Conclusions
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- World Health Organization. Ten Threats to Global Health in 2019. Available online: https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019 (accessed on 14 January 2020).
- Gómez-Gómez, B.; Cornejo-Juárez, P. Do we need antifungal stewardship? Curr. Treat. Options Infect. Dis. 2019, 11, 81–91. [Google Scholar] [CrossRef]
- Van Daele, R.; Spriet, I.; Wauters, J.; Maertens, J.; Mercier, T.; Van Hecke, S.; Brüggemann, R. Antifungal drugs: What brings the future? Med. Mycol. 2019, 57, S328–S343. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Perfect, J.R. The antifungal pipeline: A reality check. Nat. Rev. Drug Discov. 2017, 16, 603–616. [Google Scholar] [CrossRef] [Green Version]
- Rautemaa-Richardson, R.; Rautemaa, V.; Al-Wathiqi, F.; Moore, C.B.; Craig, L.; Felton, T.W.; Muldoon, E.G. Impact of a diagnostics-driven antifungal stewardship programme in a uk tertiary referral teaching hospital. J. Antimicrob. Chemother. 2018, 73, 3488–3495. [Google Scholar] [CrossRef]
- Whitney, L.; Al-Ghusein, H.; Glass, S.; Koh, M.; Klammer, M.; Ball, J.; Youngs, J.; Wake, R.; Houston, A.; Bicanic, T. Effectiveness of an antifungal stewardship programme at a london teaching hospital 2010–2016. J. Antimicrob. Chemother. 2019, 74, 234–241. [Google Scholar] [CrossRef]
- Barnes, R.A.; Stocking, K.; Bowden, S.; Poynton, M.H.; White, P.L. Prevention and diagnosis of invasive fungal disease in high-risk patients within an integrative care pathway. J. Infect. 2013, 67, 206–214. [Google Scholar] [CrossRef]
- Rajendran, R.; Sherry, L.; Deshpande, A.; Johnson, E.M.; Hanson, M.F.; Williams, C.; Munro, C.A.; Jones, B.L.; Ramage, G. A prospective surveillance study of candidaemia: Epidemiology, risk factors, antifungal treatment and outcome in hospitalized patients. Front. Microbiol. 2016, 7, 915. [Google Scholar] [CrossRef] [Green Version]
- Kullberg, B.J.; Arendrup, M.C. Invasive candidiasis. N. Engl. J. Med. 2015, 373, 1445–1456. [Google Scholar] [CrossRef] [Green Version]
- Wiederhold, N.P. Antifungal resistance: Current trends and future strategies to combat. Infect. Drug Resist. 2017, 10, 249–259. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Andruszko, B.; Dodds Ashley, E. Antifungal stewardship: An emerging practice in antimicrobial stewardship. Curr. Clin. Micro. Rep. 2016, 3, 111–119. [Google Scholar] [CrossRef]
- bioMérieux. Practical Guide to Antimicrobial Stewardship in Hospitals. Available online: http://bsac.org.uk/wp-content/uploads/2013/07/Stewardship-Booklet-Practical-Guide-to-Antimicrobial-Stewardship-in-Hospitals.pdf (accessed on 14 January 2020).
- National Institute of Clinical Excellence. Antimicrobial Stewardship Quality Standard (QS121). Available online: https://www.nice.org.uk/guidance/qs121 (accessed on 15 January 2020).
- Nathwani, D.; Sneddon, J.; Patton, A.; Malcolm, W. Antimicrobial stewardship in scotland: Impact of a national programme. Antimicrob. Resist. Infect. Control 2012, 1, 7. [Google Scholar] [CrossRef] [Green Version]
- Center for Disease Control. Fungal Diseases: Antifungal Resistance. Available online: https://www.cdc.gov/fungal/antifungal-resistance.html (accessed on 15 January 2020).
- Richardson, M.D. An introduction to antifungal stewardship. J. Antimicrob. Chemother. 2016, 71, ii3. [Google Scholar] [CrossRef] [Green Version]
- Bueid, A.; Howard, S.J.; Moore, C.B.; Richardson, M.D.; Harrison, E.; Bowyer, P.; Denning, D.W. Azole antifungal resistance in aspergillus fumigatus: 2008 and 2009. J. Antimicrob. Chemother. 2010, 65, 2116–2118. [Google Scholar] [CrossRef] [PubMed]
- Odds, F.C.; Hanson, M.F.; Davidson, A.D.; Jacobsen, M.D.; Wright, P.; Whyte, J.A.; Gow, N.A.R.; Jones, B.L. One year prospective survey of candida bloodstream infections in scotland. J. Med. Microbiol. 2007, 56, 1066–1075. [Google Scholar] [CrossRef] [PubMed]
- Muñoz, P.; Valerio, M.; Vena, A.; Bouza, E. Antifungal stewardship in daily practice and health economic implications. Mycoses 2015, 58 (Suppl. 2), 14–25. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Agrawal, S.; Barnes, R.; Bruggemann, R.J.; Rautemaa-Richardson, R.; Warris, A. The role of the multidisciplinary team in antifungal stewardship. J. Antimicrob. Chemother. 2016, 71, ii37–ii42. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hare, D.; Coates, C.; Kelly, M.; Cottrell, E.; Connolly, E.; Muldoon, E.G.; O’ Connell, B.; Rogers, T.R.; Talento, A.F. Antifungal stewardship in critical care: Implementing a diagnostics-driven care pathway in the management of invasive candidiasis. Infect. Prev. Pract. 2020, 2, 100047. [Google Scholar] [CrossRef]
- Barnes, R.A.; White, P.L.; Bygrave, C.; Evans, N.; Healy, B.; Kell, J. Clinical impact of enhanced diagnosis of invasive fungal disease in high-risk haematology and stem cell transplant patients. J. Clin. Pathol. 2009, 62, 64–69. [Google Scholar] [CrossRef] [PubMed]
- Cottom, L.; Jones, B. Optimising antifungal stewardship: An evaluation of antifungal use in intensive care. In Proceedings of the Mycology Conference 2020, London, UK, 13–14 March 2020. [Google Scholar]
- Lynch, B.L.; Rogers, T. Survey of compliance to the bsmm best practice recommendations on the diagnosis of serious fungal infections. In Proceedings of the Irish Society of Clinical Microbiology Meeting, Dublin, Ireland, 21–22 October 2016. [Google Scholar]
- Talento, A.F.; Dunne, K.; Joyce, E.A.; Palmer, M.; Johnson, E.; White, P.L.; Springer, J.; Loeffler, J.; Ryan, T.; Collins, D.; et al. A prospective study of fungal biomarkers to improve management of invasive fungal diseases in a mixed specialty critical care unit. J. Crit. Care 2017, 40, 119–127. [Google Scholar] [CrossRef] [PubMed]
- Public Health England. English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR) Report 2019 to 2020. Available online: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/936199/ESPAUR_Report_2019-20.pdf (accessed on 11 December 2020).
- NHS England. Commissioning for Quality and Innovation (CQUINN). Available online: https://www.england.nhs.uk/nhs-standard-contract/cquin/ (accessed on 17 March 2020).
- Whitney, L.; Hall, N.; Leach, M. Improving Value in Specialised Services: Antifungal Stewardship Implementation Pack (v7). Available online: https://www.england.nhs.uk/wp-content/uploads/2019/03/PSS1-meds-optimisation-trigger-5-antifungal-stewardship-implementation-pack-v7.pdf (accessed on 12 December 2020).
- Borman, A.M.; Palmer, M.D.; Fraser, M.; Patterson, Z.; Mann, C.; Oliver, D.; Linton, C.J.; Gough, M.; Brown, P.; Dzietczyk, A.; et al. COVID-19-associated invasive aspergillosis: Data from the uk national mycology reference laboratory. J. Clin. Microbiol. 2020, 59, e02136-20. [Google Scholar] [CrossRef]
- Eades, C.P.; Armstrong-James, D.P.H. Invasive fungal infections in the immunocompromised host: Mechanistic insights in an era of changing immunotherapeutics. Med. Mycol. 2019, 57, S307–S317. [Google Scholar] [CrossRef] [PubMed]
- Scotland, H.I. Good Practice Recommendations for Treatment of Candidaemia and the Use of Antifungal Agents. Available online: https://www.sapg.scot/media/5442/gprs-for-treatment-of-candidaemia-and-use-of-antifungal-agents.pdf (accessed on 23 April 2020).
- Schelenz, S.; Barnes, R.A.; Barton, R.C.; Cleverley, J.R.; Lucas, S.B.; Kibbler, C.C.; Denning, D.W. British society for medical mycology best practice recommendations for the diagnosis of serious fungal diseases. Lancet Infect. Dis. 2015, 15, 461–474. [Google Scholar] [CrossRef]
- Donnelly, J.P.; Chen, S.C.; Kauffman, C.A.; Steinbach, W.J.; Baddley, J.W.; Verweij, P.E.; Clancy, C.J.; Wingard, J.R.; Lockhart, S.R.; Groll, A.H.; et al. Revision and update of the consensus definitions of invasive fungal disease from the european organization for research and treatment of cancer and the mycoses study group education and research consortium. Clin. Infect. Dis. 2020, 71, 1367–1376. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lagrou, K.; Duarte, R.F.; Maertens, J. Standards of care: What is considered ’best practice’ for the management of invasive fungal infections? A haematologist’s and a mycologist’s perspective. J. Antimicrob. Chemother. 2019, 74, ii3–ii8. [Google Scholar] [CrossRef] [Green Version]
- NICE (National Institute for Health and Care Excellence). Fungitell for Antifungal Treatment Stratification (mib 118). Available online: https://www.nice.org.uk/guidance/mib118 (accessed on 23 April 2021).
- Finkelman, M.A. Specificity influences in (1-->3)-beta-d-glucan-supported diagnosis of invasive fungal disease. J. Fungi 2020, 7, 14. [Google Scholar] [CrossRef]
- Sanguinetti, M.; Posteraro, B.; Beigelman-Aubry, C.; Lamoth, F.; Dunet, V.; Slavin, M.; Richardson, M.D. Diagnosis and treatment of invasive fungal infections: Looking ahead. J. Antimicrob. Chemother. 2019, 74, ii27–ii37. [Google Scholar] [CrossRef] [Green Version]
- Verweij, P.E.; Chowdhary, A.; Melchers, W.J.; Meis, J.F. Azole resistance in aspergillus fumigatus: Can we retain the clinical use of mold-active antifungal azoles? Clin. Infect. Dis. 2016, 62, 362–368. [Google Scholar] [CrossRef] [Green Version]
- Huppler, A.R.; Fisher, B.T.; Lehrnbecher, T.; Walsh, T.J.; Steinbach, W.J. Role of molecular biomarkers in the diagnosis of invasive fungal diseases in children. J. Pediatric Infect. Dis. Soc. 2017, 6, S32–S44. [Google Scholar] [CrossRef] [Green Version]
- Micallef, C.; Ashiru-Oredope, D.; Hansraj, S.; Denning, D.W.; Agrawal, S.G.; Manuel, R.J.; Schelenz, S.; Guy, R.; Muller-Pebody, B.; Patel, R.; et al. An investigation of antifungal stewardship programmes in england. J. Med. Microbiol. 2017, 66, 1581–1589. [Google Scholar] [CrossRef]
- McMullan, R. Rapid Diagnostic Tests and Treatment Opportunities for Fungal Infection in Critically Ill Patients. Available online: http://www.isrctn.com/ISRCTN43895480 (accessed on 23 April 2021).
- Hobson, R.; Barnes, R.; UK Clinical Mycology Netowork Management Group; European Society of Clinical Microbiology and Infectious Diseases Fungal Infection Study. Identification and Sensitivity Testing of Yeast Isolates—Best Practice Guide. January 2012. [Google Scholar]
- Aguado, J.M.; Vázquez, L.; Fernández-Ruiz, M.; Villaescusa, T.; Ruiz-Camps, I.; Barba, P.; Silva, J.T.; Batlle, M.; Solano, C.; Gallardo, D.; et al. Serum galactomannan versus a combination of galactomannan and polymerase chain reaction-based aspergillus DNA detection for early therapy of invasive aspergillosis in high-risk hematological patients: A randomized controlled trial. Clin. Infect. Dis. 2015, 60, 405–414. [Google Scholar] [CrossRef]
- Morrissey, C.O.; Chen, S.C.; Sorrell, T.C.; Milliken, S.; Bardy, P.G.; Bradstock, K.F.; Szer, J.; Halliday, C.L.; Gilroy, N.M.; Moore, J.; et al. Galactomannan and pcr versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: A randomised controlled trial. Lancet. Infect. Dis. 2013, 13, 519–528. [Google Scholar] [CrossRef]
- Marr, K.A.; Laverdiere, M.; Gugel, A.; Leisenring, W. Antifungal therapy decreases sensitivity of the aspergillus galactomannan enzyme immunoassay. Clin. Infect. Dis. 2005, 40, 1762–1769. [Google Scholar] [CrossRef]
- Eigl, S.; Prattes, J.; Reinwald, M.; Thornton, C.R.; Reischies, F.; Spiess, B.; Neumeister, P.; Zollner-Schwetz, I.; Raggam, R.B.; Flick, H.; et al. Influence of mould-active antifungal treatment on the performance of the aspergillus-specific bronchoalveolar lavage fluid lateral-flow device test. Int. J. Antimicrob. Agents 2015, 46, 401–405. [Google Scholar] [CrossRef]
- Verweij, P.E.; Ananda-Rajah, M.; Andes, D.; Arendrup, M.C.; Brüggemann, R.J.; Chowdhary, A.; Cornely, O.A.; Denning, D.W.; Groll, A.H.; Izumikawa, K.; et al. International expert opinion on the management of infection caused by azole-resistant aspergillus fumigatus. Drug Resist. Updates 2015, 21–22, 30–40. [Google Scholar] [CrossRef]
- Bassetti, M.; Righi, E.; Montravers, P.; Cornely, O.A. What has changed in the treatment of invasive candidiasis? A look at the past 10 years and ahead. J. Antimicrob. Chemother. 2018, 73, i14–i25. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Perlin, D.S.; Rautemaa-Richardson, R.; Alastruey-Izquierdo, A. The global problem of antifungal resistance: Prevalence, mechanisms, and management. Lancet Infect. Dis. 2017, 17, e383–e392. [Google Scholar] [CrossRef]
- GOV.UK. Coronavirus (COVID-19) in the UK. Cases in the United Kingdom. Available online: https://coronavirus.data.gov.uk/details/cases (accessed on 30 May 2021).
- Rhodes, J.; Abdolrasouli, A.; Farrer, R.A.; Cuomo, C.A.; Aanensen, D.M.; Armstrong-James, D.; Fisher, M.C.; Schelenz, S. Genomic epidemiology of the uk outbreak of the emerging human fungal pathogen candida auris. Emerg. Microbes Infect. 2018, 7, 43. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Perlin, D.S.; Wiederhold, N.P. Culture-independent molecular methods for detection of antifungal resistance mechanisms and fungal identification. J. Infect. Dis. 2017, 216, S458–S465. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- White, P.L.; Backx, M.; Barnes, R.A. Diagnosis and management of pneumocystis jirovecii infection. Expert Rev. Anti-Infect. Ther. 2017, 15, 435–447. [Google Scholar] [CrossRef]
- Chong, G.M.; Vonk, A.G.; Meis, J.F.; Dingemans, G.J.; Houbraken, J.; Hagen, F.; Gaajetaan, G.R.; van Tegelen, D.W.; Simons, G.F.; Rijnders, B.J. Interspecies discrimination of a. Fumigatus and siblings A. lentulus and A. felis of the aspergillus section fumigati using the aspergenius((r)) assay. Diagn. Microbiol. Infect. Dis. 2017, 87, 247–252. [Google Scholar] [CrossRef] [PubMed]
- Trevino-Rangel, R.J.; Villanueva-Lozano, H.; Bonifaz, A.; Castanon-Olivares, L.R.; Andrade, A.; Becerril-Garcia, M.A.; Martinez-Resendez, M.F.; Ayala-Gaytan, J.; Montoya, A.M.; Gonzalez, G.M. Species distribution and antifungal susceptibility patterns of aspergillus isolates from clinical specimens and soil samples in mexico. Med. Mycol. 2021. online ahead of print. [Google Scholar]
AFS MDT Team | |||
---|---|---|---|
Team Leader | |||
Dedicated physicians and pharmacists are required to support a successful AFS programme | |||
The core members should have knowledge of, and experience in the following aspects: | |||
Clinical management of relevant patient populations | Fungal epidemiology and susceptibility patterns | Diagnosis of invasive fungal disease | Pharmacokinetics (PK), dosing and drug–drug interactions of antifungal drugs |
Core team members: | |||
ID physician | Clinical pharmacist | Microbiologist (with knowledge of mycology) | Specialists e.g., haematologist, intensive care unit physician, paediatric infectious diseases specialist, etc. |
Additional team members: | |||
Computer system analyst | Infection control specialist | Hospital epidemiologist | |
Supporting teams: | |||
The key team members must work closely with the relevant teams | |||
Pharmacy team | Infection control committee | Hospital administration | Medical staff leadership |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Talento, A.F.; Qualie, M.; Cottom, L.; Backx, M.; White, P.L. Lessons from an Educational Invasive Fungal Disease Conference on Hospital Antifungal Stewardship Practices across the UK and Ireland. J. Fungi 2021, 7, 801. https://doi.org/10.3390/jof7100801
Talento AF, Qualie M, Cottom L, Backx M, White PL. Lessons from an Educational Invasive Fungal Disease Conference on Hospital Antifungal Stewardship Practices across the UK and Ireland. Journal of Fungi. 2021; 7(10):801. https://doi.org/10.3390/jof7100801
Chicago/Turabian StyleTalento, Alida Fe, Malcolm Qualie, Laura Cottom, Matthijs Backx, and P. Lewis White. 2021. "Lessons from an Educational Invasive Fungal Disease Conference on Hospital Antifungal Stewardship Practices across the UK and Ireland" Journal of Fungi 7, no. 10: 801. https://doi.org/10.3390/jof7100801